These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease. Cimmino M; Nardone M; Cavaliere M; Plantulli A; Sepe A; Esposito V; Mazzarella G; Raia V Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1097-101. PubMed ID: 16365224 [TBL] [Abstract][Full Text] [Related]
4. Is a longer time interval between recombinant human deoxyribonuclease (dornase alfa) and chest physiotherapy better? A multi-center, randomized crossover trial. Wilson CJ; Robbins LJ; Murphy JM; Chang AB Pediatr Pulmonol; 2007 Dec; 42(12):1110-6. PubMed ID: 17955550 [TBL] [Abstract][Full Text] [Related]
5. Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial. Bakker EM; Volpi S; Salonini E; Müllinger B; Kroneberg P; Bakker M; Hop WC; Assael BM; Tiddens HA Pediatr Pulmonol; 2014 Feb; 49(2):154-61. PubMed ID: 23913868 [TBL] [Abstract][Full Text] [Related]
6. Sino nasal inhalation of isotonic versus hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis - Results of a multicenter, prospective, randomized, double-blind, controlled trial. Mainz JG; Schumacher U; Schädlich K; Hentschel J; Koitschev C; Koitschev A; Riethmüller J; Prenzel F; Sommerburg O; Wiedemann B; Staab D; Gleiber W; Fischer R; Beck JF; Arnold C; J Cyst Fibros; 2016 Nov; 15(6):e57-e66. PubMed ID: 27267518 [TBL] [Abstract][Full Text] [Related]
7. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis. Fitzgerald DA; Hilton J; Jepson B; Smith L Pediatrics; 2005 Oct; 116(4):e549-54. PubMed ID: 16147970 [TBL] [Abstract][Full Text] [Related]
8. Management of chronic rhinosinusitis in CF. Mainz JG; Koitschev A J Cyst Fibros; 2009 Jun; 8 Suppl 1():S10-4. PubMed ID: 19460681 [TBL] [Abstract][Full Text] [Related]
9. Nasally inhaled dornase alfa in the postoperative management of chronic sinusitis due to cystic fibrosis. Raynor EM; Butler A; Guill M; Bent JP Arch Otolaryngol Head Neck Surg; 2000 May; 126(5):581-3. PubMed ID: 10807324 [TBL] [Abstract][Full Text] [Related]
10. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities. Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW; J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506 [TBL] [Abstract][Full Text] [Related]
11. [An update on cystic fibrosis for the ENT-specialist]. Rozsasi A; Keck T Laryngorhinootologie; 2003 Oct; 82(10):715-25; quiz 726-30. PubMed ID: 14593571 [TBL] [Abstract][Full Text] [Related]
12. Treatment of chronic rhinosinusitis with dornase alfa in patients with cystic fibrosis: a systematic review. Shah GB; De Keyzer L; Russell JA; Halderman A Int Forum Allergy Rhinol; 2018 Jun; 8(6):729-736. PubMed ID: 29323796 [TBL] [Abstract][Full Text] [Related]
13. Does the timing of inhaled dornase alfa matter? van der Giessen L J Cyst Fibros; 2009 Jun; 8 Suppl 1():S6-9. PubMed ID: 19460684 [TBL] [Abstract][Full Text] [Related]
14. Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double-blind, randomized, placebo-controlled, cross-over pilot study. Videler WJ; van Drunen CM; Reitsma JB; Fokkens WJ Rhinology; 2008 Jun; 46(2):92-8. PubMed ID: 18575008 [TBL] [Abstract][Full Text] [Related]
15. Medical management of chronic rhinosinusitis in cystic fibrosis: a systematic review. Liang J; Higgins T; Ishman SL; Boss EF; Benke JR; Lin SY Laryngoscope; 2014 Jun; 124(6):1308-13. PubMed ID: 24338982 [TBL] [Abstract][Full Text] [Related]
16. Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation. Bakker EM; Volpi S; Salonini E; van der Wiel-Kooij EC; Sintnicolaas CJ; Hop WC; Assael BM; Merkus PJ; Tiddens HA Eur Respir J; 2011 Dec; 38(6):1328-35. PubMed ID: 21737560 [TBL] [Abstract][Full Text] [Related]
17. Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebo-controlled pilot study. Mainz JG; Schädlich K; Schien C; Michl R; Schelhorn-Neise P; Koitschev A; Koitschev C; Keller PM; Riethmüller J; Wiedemann B; Beck JF Drug Des Devel Ther; 2014; 8():209-17. PubMed ID: 24596456 [TBL] [Abstract][Full Text] [Related]
18. Randomized trial of efficacy and safety of dornase alfa delivered by eRapid nebulizer in cystic fibrosis patients. Sawicki GS; Chou W; Raimundo K; Trzaskoma B; Konstan MW J Cyst Fibros; 2015 Nov; 14(6):777-83. PubMed ID: 25921451 [TBL] [Abstract][Full Text] [Related]
19. Dornase alpha and exhaled NO in cystic fibrosis. Grasemann H; Lax H; Treseler JW; Colin AA Pediatr Pulmonol; 2004 Nov; 38(5):379-85. PubMed ID: 15390350 [TBL] [Abstract][Full Text] [Related]
20. Amphotericin B irrigation for the treatment of chronic rhinosinusitis without nasal polyps: a randomized, placebo-controlled, double-blind study. Liang KL; Su MC; Shiao JY; Tseng HC; Hsin CH; Lin JF; Jiang RS Am J Rhinol; 2008; 22(1):52-8. PubMed ID: 18284860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]